BC Innovations | Jul 14, 2011
Distillery Therapeutics

Indication: Renal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Renal disease Polycystic kidney disease (PKD) Aurora kinase A (AURKA; Aurora-A); polycystic kidney disease 2 (PKD2) Studies in patient samples and in cell culture suggest that...
BC Innovations | Jul 1, 2010
Targets & Mechanisms

PKD: cease and de-cyst

Marketed treatments for polycystic kidney disease manage symptoms but do not slow disease progression. A research team led by Genzyme Corp. now has shown that blocking biosynthesis of the glycosphingolipid glucosylceramide could help treat the...
BC Week In Review | Jun 3, 1996
Company News

Albert Einstein College of Medicine other research news

Researchers reported the discovery of a second gene associated with autosomal dominant polycystic kidney disease (ADPKD). PKD, the most common of all life-threatening genetic diseases, causes the development of fluid-filled cysts in the kidney that...
Items per page:
1 - 3 of 3